Sulbactam-durlobactam from Innoviva should be approved by the US FDA to treat ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia.

The US Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted 12-0 in favour of approval of sulbactam-durlobactam for the treatment of adults with ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia caused by susceptible strains, according to…

Walk-in Interview for Multiple Positions at Umedica Laboratories Pvt Ltd for B. Pharma/ M. Pharma/ B. Sc./ M. Sc/ ITI/ Diploma – 23 April 2023

UMEDICA is a part of the Amoli Group of Companies, manufacturing and exporting a wide range of formulations viz; Injectables, Tablets, Capsules, Suspensions, Dry Syrups, etc. UMEDICA offers a diverse product portfolio with a patient-centric approach comprising of antibiotics, anti-diabetics,…

Walk-in Interview for B. Pharma/ M. Pharma/ B. Sc./ M. Sc./ Diploma/ ITI for Multiple Positions at Granules India Ltd – 22 April 2023

Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing presence across the world. Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API,…

Back to top

Registration Form


This will close in 0 seconds

WhatsApp Join Telegram